Insufficient scRNA-seq data for expression of MYCN at single-cell level.
Insufficient scRNA-seq data for expression of MYCN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 208.51 | 2542 / 2642 | 95% | 25.03 | 669 / 705 |
ovary | 90% | 217.73 | 162 / 180 | 85% | 25.43 | 365 / 430 |
thymus | 100% | 317.12 | 652 / 653 | 35% | 4.00 | 211 / 605 |
stomach | 84% | 176.35 | 300 / 359 | 42% | 8.88 | 121 / 286 |
intestine | 72% | 54.86 | 693 / 966 | 39% | 4.41 | 208 / 527 |
bladder | 62% | 48.95 | 13 / 21 | 38% | 8.54 | 192 / 504 |
esophagus | 62% | 46.33 | 891 / 1445 | 33% | 8.14 | 61 / 183 |
kidney | 88% | 151.38 | 78 / 89 | 6% | 0.41 | 58 / 901 |
adrenal gland | 29% | 24.67 | 76 / 258 | 56% | 17.40 | 128 / 230 |
uterus | 42% | 26.42 | 71 / 170 | 37% | 9.27 | 171 / 459 |
breast | 42% | 34.67 | 195 / 459 | 26% | 3.12 | 295 / 1118 |
skin | 40% | 77.55 | 727 / 1809 | 21% | 4.92 | 101 / 472 |
lung | 28% | 27.75 | 162 / 578 | 24% | 6.37 | 274 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 47% | 6.19 | 21 / 45 |
heart | 44% | 31.02 | 381 / 861 | 0% | 0 | 0 / 0 |
liver | 25% | 34.62 | 57 / 226 | 19% | 2.25 | 76 / 406 |
adipose | 36% | 31.43 | 429 / 1204 | 0% | 0 | 0 / 0 |
spleen | 30% | 24.64 | 73 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 24% | 18.24 | 316 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 5% | 2.71 | 18 / 328 | 18% | 1.53 | 32 / 178 |
prostate | 14% | 8.06 | 34 / 245 | 0% | 0 | 0 / 502 |
muscle | 5% | 2.87 | 43 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.17 | 3 / 80 |
peripheral blood | 0% | 0.17 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0019900 | Molecular function | kinase binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MYCN |
Protein name | MYCN proto-oncogene, bHLH transcription factor Alternative protein MYCN N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37) (bHLHe37) |
Synonyms | NMYC BHLHE37 |
Description | FUNCTION: Positively regulates the transcription of MYCNOS in neuroblastoma cells. . |
Accessions | L8E744 ENST00000281043.4 P04198 ENST00000638417.1 A0A5P8TXN7 A0A1W2PPD9 |